Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGR | P06401 | 7/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 1/20 | 0.37 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.37 |
| ▸ | NOS3 | P29474 | 1/20 | 0.34 |
| ▸ | NOS2 | P35228 | 1/20 | 0.34 |
| ▸ | TERT | O14746 | 1/20 | 0.33 |
| ▸ | DRD2 | P14416 | 1/20 | 0.33 |
| ▸ | DRD3 | P35462 | 1/20 | 0.33 |
| ▸ | AR | P10275 | 4/20 | 0.33 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.33 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.33 |
| ▸ | HTR2C | P28335 | 1/20 | 0.32 |
| ▸ | HTR7 | P34969 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13248018 | 0.81 | PGR (0.47) | PGRCYP19A1ADRA2AESR1ESR2 | |
| SCHEMBL856025 | 0.78 | MAOB (0.47) | CYP19A1SRD5A1 | |
| SCHEMBL30779660 | 0.76 | PARP1 (0.54) | PGRCYP19A1ADRA2ATERTPARP1 | |
| SCHEMBL18331030 | 0.76 | PARP1 (0.54) | PGRCYP19A1ADRA2ATERTPARP1 | |
| SCHEMBL30715532 | 0.73 | CYP19A1 (0.40) | PGRCYP19A1ADRA2ATERTPARP1 | |
| SCHEMBL30989916 | 0.72 | CYP19A1 (0.39) | PGRCYP19A1ADRA2ATERTPARP1 | |
| SCHEMBL5684576 | 0.71 | PGR (0.47) | PGRCYP19A1NOS3NOS2DRD2 | |
| SCHEMBL29517854 | 0.71 | PGR (0.47) | PGRCYP19A1NOS3NOS2DRD2 | |
| SCHEMBL9740321 | 0.69 | MAOA (0.52) | CYP19A1 | |
| SCHEMBL24727216 | 0.68 | POLB (0.37) | PGRAR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10954445-B2 | Liquid crystal composition | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2021-03-23 | — | — | US | disclosed |
| US-10858591-B2 | Stabilizer and liquid crystal composition comprising same | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2020-12-08 | — | — | US | disclosed |
| US-10767113-B2 | Liquid crystal compound containing 2,3,4-trisubstituted benzene and composition thereof | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2020-09-08 | — | — | US | disclosed |
| US-10759997-B2 | Polymerizable compound, liquid crystal medium containing same and liquid crystal display device | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2020-09-01 | — | — | US | disclosed |
| US-10472570-B2 | Highly vertical dielectric liquid crystal compound, liquid crystal composition, and liquid crystal display device | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2019-11-12 | — | — | US | disclosed |
| US-20190100697-A1 | LIQUID CRYSTAL COMPOSITION | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2019-04-04 | — | — | US | disclosed |
| US-20180119012-A1 | HIGHLY VERTICAL DIELECTRIC LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2018-05-03 | — | — | US | disclosed |
| US-20180094191-A1 | LIQUID CRYSTAL COMPOUND CONTAINING 2,3,4-TRISUBSTITUTED BENZENE AND COMPOSITION THEREOF | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO LTD (CN) | 2018-04-05 | — | — | US | disclosed |
| US-20170349833-A1 | STABILIZER AND LIQUID CRYSTAL COMPOSITION COMPRISING SAME | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIALS CO., LTD. (CN) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10858591-B2 | Stabilizer and liquid crystal composition comprising same | BCL2L2, NCAPD2, ZYX | PGR 3767/4885CYP19A1 2984/4885ADRA2A 2973/4885 |
| US-20170349833-A1 | STABILIZER AND LIQUID CRYSTAL COMPOSITION COMPRISING SAME | LBR, CTNND1, CRYZ | PGR 3847/4885CYP19A1 3006/4885ADRA2A 1025/4885 |
| US-20180119012-A1 | HIGHLY VERTICAL DIELECTRIC LIQUID CRYSTAL COMPOUND, LIQUID CRYSTAL COMPOSITION, AND LIQUID CRYSTAL DISPLAY DEVICE | CCNB1, FLNB, CXCR1 | PGR 2213/4885CYP19A1 161/4885ADRA2A 1831/4885 |
| US-10472570-B2 | Highly vertical dielectric liquid crystal compound, liquid crystal composition, and liquid crystal display device | CCNB1, FLNB, CXCR1 | PGR 2213/4885CYP19A1 161/4885ADRA2A 1831/4885 |
| US-10759997-B2 | Polymerizable compound, liquid crystal medium containing same and liquid crystal display device | BPHL, KLK3, NEFM | PGR 1194/4885CYP19A1 434/4885ADRA2A 4750/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.